J Clin Neurol.  2020 Jan;16(1):19-28. 10.3988/jcn.2020.16.1.19.

Association between Retinal Vascular Geometric Changes and Cognitive Impairment: A Systematic Review and Meta-Analysis

Affiliations
  • 1Department of Medical Informatics, Medical School of Nantong University, Nantong, China.
  • 2Department of Ophthalmology, Affiliated Hospital of Nantong University, Nantong, China. sangam@ntu.edu.cn

Abstract

BACKGROUND AND PURPOSE
Previous studies have explored the association between retinal vascular changes and cognitive impairment. The retinal vasculature shares some characteristics with the cerebral vasculature, and quantitative changes in it could indicate cognitive impairment. Hence, a comprehensive meta-analysis was performed to clarify the potential relationship between retinal vascular geometric changes and cognitive impairment.
METHODS
Relevant databases were scrupulously and systematically searched for retinal vascular geometric changes including caliber, tortuosity, and fractal dimension (FD), and for cognitive impairment. The Newcastle-Ottawa Scale was used to evaluate the methodological quality of included studies. RevMan was used to perform the meta-analysis and detect publication bias. Sensitivity analyses were also performed.
RESULTS
Five studies that involved 2,343 subjects were finally included in the meta-analysis. The results showed that there was no significant association between central retinal artery equivalents (Z=1.17) or central retinal venular equivalents (Z=1.74) and cognitive impairment (both p>0.05). Similarly, no significant difference was detected in retinal arteriolar tortuosity (Z=0.91) and venular tortuosity (Z=1.31) (both p>0.05). However, the retinal arteriolar FD (mean difference: −0.03, 95% CI: −0.05, −0.01) and venular FD (mean difference: −0.03, 95% CI: −0.05, −0.02) were associated with cognitive impairment.
CONCLUSIONS
A smaller retinal microvascular FD might be associated with cognitive impairment. Further large-sample and well-controlled original studies are required to confirm the present findings.

Keyword

retina; cognitive impairment; meta-analysis; retinal vessels

MeSH Terms

Cognition Disorders*
Fractals
Publication Bias
Retina
Retinal Artery
Retinal Vessels
Retinaldehyde*
Retinaldehyde

Figure

  • Fig. 1 Flow chart of included and excluded studies.

  • Fig. 2 Details of the quality assessment of studies using the Newcastle-Ottawa Scale.

  • Fig. 3 Forest plot of the association between the retinal vascular caliber and cognitive impairment. CRAE: central retinal arteriolar equivalents, CRVE: central retinal venular equivalents.

  • Fig. 4 Forest plot of the association between the retinal vascular tortuosity and cognitive impairment. TORa: arteriolar tortuosity, TORv: venular tortuosity.

  • Fig. 5 Forest plot of the association between the retinal vascular FD and cognitive impairment. FD: fractal dimension, FDa: arteriolar FD, FDv: venular FD.

  • Fig. 6 Funnel plot of publication bias for the association between the retinal vascular caliber and cognitive impairment. CRAE: central retinal arteriolar equivalents, CRVE: central retinal venular equivalents, MD: mean difference, SE: standard error.

  • Fig. 7 Funnel plot of publication bias for the association between the retinal vascular tortuosity and cognitive impairment. MD: mean difference, SE: standard error, TORa: arteriolar tortuosity, TORv: venular tortuosity.

  • Fig. 8 Funnel plot of the association between the retinal vascular FD and cognitive impairment. FD: fractal dimension, FDa: arteriolar FD, FDv: venular FD, MD: mean difference, SE: standard error.


Reference

1. Reitz C, Brayne C, Mayeux R. Epidemiology of Alzheimer disease. Nat Rev Neurol. 2011; 7:137–152.
Article
2. Petersen RC, Roberts RO, Knopman DS, Geda YE, Cha RH, Pankratz VS, et al. Prevalence of mild cognitive impairment is higher in men. The Mayo Clinic Study of Aging. Neurology. 2010; 75:889–897.
Article
3. Jiang YS. Retinal microvascular pathology and vascular risk factors in cognitive impairment: a cross-sectional study [dissertation]. Wuhan: Wuhan University;2015. 1–83.
4. James BD, Leurgans SE, Hebert LE, Scherr PA, Yaffe K, Bennett DA. Contribution of Alzheimer disease to mortality in the United States. Neurology. 2014; 82:1045–1050.
Article
5. Lesage SR, Mosley TH, Wong TY, Szklo M, Knopman D, Catellier DJ, et al. Retinal microvascular abnormalities and cognitive decline: the ARIC 14-year follow-up study. Neurology. 2009; 73:862–868.
Article
6. Kim DH, Chaves PH, Newman AB, Klein R, Sarnak MJ, Newton E, et al. Retinal microvascular signs and disability in the Cardiovascular Health Study. Arch Ophthalmol. 2012; 130:350–356.
Article
7. Ikram MK, De Jong FJ, Van Dijk EJ, Prins ND, Hofman A, Breteler MM, et al. Retinal vessel diameters and cerebral small vessel disease: the Rotterdam Scan Study. Brain. 2006; 129:182–188.
Article
8. Schrijvers EM, Buitendijk GH, Ikram MK, Koudstaal PJ, Hofman A, Vingerling JR, et al. Retinopathy and risk of dementia: the Rotterdam Study. Neurology. 2012; 79:365–370.
Article
9. Kawasaki R, Cheung N, Mosley T, Islam AF, Sharrett AR, Klein R, et al. Retinal microvascular signs and 10-year risk of cerebral atrophy: the Atherosclerosis Risk in Communities (ARIC) study. Stroke. 2010; 41:1826–1828.
Article
10. Cheung N, Mosley T, Islam A, Kawasaki R, Sharrett AR, Klein R, et al. Retinal microvascular abnormalities and subclinical magnetic resonance imaging brain infarct: a prospective study. Brain. 2010; 133:1987–1993.
Article
11. Dashtbozorg B, Mendonça AM, Penas S, Campilho A. RetinaCAD, a system for the assessment of retinal vascular changes. Conf Proc IEEE Eng Med Biol Soc. 2014; 2014:6328–6331.
Article
12. Ponto KA, Werner DJ, Wiedemer L, Laubert-Reh D, Schuster AK, Nickels S, et al. Retinal vessel metrics: normative data and their use in systemic hypertension: results from the Gutenberg Health Study. J Hypertens. 2017; 35:1635–1645.
13. De Jong FJ, Schrijvers EM, Ikram MK, Koudstaal PJ, De Jong PT, Hofman A, et al. Retinal vascular caliber and risk of dementia: the Rotterdam study. Neurology. 2011; 76:816–821.
Article
14. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984; 34:939–944.
Article
15. Ridha B, Rossor M. The mini mental state examination. Pract Neurol. 2005; 5:298–303.
Article
16. Wells G. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Appl Eng Agric. 2000; 18:727–734.
17. Frost S, Kanagasingam Y, Sohrabi H, Vignarajan J, Bourgeat P, Salvado O, et al. Retinal vascular biomarkers for early detection and monitoring of Alzheimer's disease. Transl Psychiatry. 2013; 3:e233.
Article
18. Cheung CY, Ong YT, Ikram MK, Ong SY, Li X, Hilal S, et al. Microvascular network alterations in the retina of patients with Alzheimer's disease. Alzheimers Dement. 2014; 10:135–142.
Article
19. Williams MA, McGowan AJ, Cardwell CR, Cheung CY, Craig D, Passmore P, et al. Retinal microvascular network attenuation in Alzheimer's disease. Alzheimers Dement (Amst). 2015; 1:229–235.
Article
20. Cheung CY, Ong S, Ikram MK, Ong YT, Chen CP, Venketasubramanian N, et al. Retinal vascular fractal dimension is associated with cognitive dysfunction. J Stroke Cerebrovasc Dis. 2014; 23:43–50.
Article
21. Cheung CY, Hsu W, Lee ML, Wang JJ, Mitchell P, Lau QP, et al. A new method to measure peripheral retinal vascular caliber over an extended area. Microcirculation. 2010; 17:495–503.
22. Knudtson MD, Lee KE, Hubbard LD, Wong TY, Klein R, Klein BE. Revised formulas for summarizing retinal vessel diameters. Curr Eye Res. 2003; 27:143–149.
Article
23. Hart WE, Goldbaum M, Côté B, Kube P, Nelson MR. Measurement and classification of retinal vascular tortuosity. Int J Med Inform. 1999; 53:239–252.
Article
24. Liew G, Wang JJ, Cheung N, Zhang YP, Hsu W, Lee ML, et al. The retinal vasculature as a fractal: methodology, reliability, and relationship to blood pressure. Ophthalmology. 2008; 115:1951–1956.
Article
25. Heringa SM, Bouvy WH, Van den Berg E, Moll AC, Kappelle LJ, Biessels GJ. Associations between retinal microvascular changes and dementia, cognitive functioning, and brain imaging abnormalities: a systematic review. J Cereb Blood Flow Metab. 2013; 33:983–995.
Article
26. Ding J, Patton N, Deary IJ, Strachan MW, Fowkes FG, Mitchell RJ, et al. Retinal microvascular abnormalities and cognitive dysfunction: a systematic review. Br J Ophthalmol. 2008; 92:1017–1025.
Article
27. Gatto NM, Varma R, Torres M, Wong TY, Johnson PL, Segal-Gidan F, et al. Retinal microvascular abnormalities and cognitive function in Latino adults in Los Angeles. Ophthalmic Epidemiol. 2012; 19:127–136.
Article
28. Jinnouchi H, Kitamura A, Yamagishi K, Kiyama M, Imano H, Okada T, et al. Retinal vascular changes and prospective risk of disabling dementia: the circulatory risk in communities study (CIRCS). J Atheroscler Thromb. 2017; 24:687–695.
Article
29. Jiang H, Wei Y, Shi Y, Wright CB, Sun X, Gregori G, et al. Altered macular microvasculature in mild cognitive impairment and Alzheimer disease. J Neuroophthalmol. 2018; 38:292–298.
Article
30. Ong YT, Hilal S, Cheung CY, Xu X, Chen C, Venketasubramanian N, et al. Retinal vascular fractals and cognitive impairment. Dement Geriatr Cogn Dis Extra. 2014; 4:305–313.
Article
31. Mroczkowska S, Benavente-Pérez A, Patel S, Qin L, Bentham P, Gherghel D. Retinal vascular dysfunction relates to cognitive impairment in Alzheimer disease. Alzheimer Dis Assoc Disord. 2014; 28:366–367.
Article
32. Sun X, He G, Qing H, Zhou W, Dobie F, Cai F, et al. Hypoxia facilitates Alzheimer's disease pathogenesis by up-regulating BACE1 gene expression. Proc Natl Acad Sci U S A. 2006; 103:18727–18732.
Article
33. Koike MA, Garcia FG, Kitazawa M, Green KN, Laferla FM. Long term changes in phospho-APP and tau aggregation in the 3xTg-AD mice following cerebral ischemia. Neurosci Lett. 2011; 495:55–59.
Article
34. Patton N, Aslam T, Macgillivray T, Pattie A, Deary IJ, Dhillon B. Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures. J Anat. 2005; 206:319–348.
Article
35. Murray CD. The physiological principle of minimum work I. The vascular system and the cost of blood volume. Proc Natl Acad Sci U S A. 1926; 12:207–214.
Article
36. Xu X, Jerskey BA, Cote DM, Walsh EG, Hassenstab JJ, Ladino ME, et al. Cerebrovascular perfusion among older adults is moderated by strength training and gender. Neurosci Lett. 2014; 560:26–30.
Article
37. Wang YX, Fitch RM. Vascular stiffness: measurements, mechanisms and implications. Curr Vasc Pharmacol. 2004; 2:379–384.
Article
Full Text Links
  • JCN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr